Supplementary Figure S1 . Modulated Ptc-receptor binding of Shh. (A) Shh-Ptc binding is physiologically modulated by competing Shh-Hhip interactions. Deletion of a Hhip peptide loop known to interact with the Shh zinc coordination site that also serves as the Ptc interaction site (Hhip L2 ) impairs Shh binding and restores most signaling activity. Cyclopamine (CA)-an antagonist acting downstream of Ptc-serves as a control for Shh-specific induction of C3H10T1/2 differentiation. (B) Shh-Ptc interactions are also blocked by competing unprocessed N-terminal Shh C25S peptides. The monoclonal antibody 5E1 blocks the same site. (C) Unprocessed N-terminal peptides block Shh-Ptc interactions. Unlike dual-lipidated Shh, ShhN C25S is an artificial, non-lipidated Shh variant that undergoes simple secretion without terminal processing. Proteins in ShhN C25S conditioned media and media containing gradually N-terminally truncated ShhN C25S variants were pulled down with heparin agarose (which binds all forms) or immunoprecipitated with 5E1-coupled ProteinA-agarose (which binds the exposed accessible Ptc interaction site) and analyzed by immunoblotting. Ratios between the 5E1-immunoprecipitated material and the proteins pulled down by heparin (from the same supernatants) are shown. Note that artificial N-terminal truncations restore 5E1 MoAb binding to the Ptc binding site.
Supplementary Figure S2 . Proteolytic processing of N-terminal peptides during Shh release. In contrast to dual-lipidated membrane-tethered Shh, artificial ShhN C25S is not lipidated and therefore undergoes direct secretion. C-terminally hemagglutinin (HA)-tagged Shh HA and non-palmitoylated, but cholesteroylated Shh C25A;HA were also analyzed. The latter two proteins carry an extended C-terminal membrane anchor (G 198 represents the cholesterol-modified glycine; underlined italicized letters represent the tag) [12] ). Proteins in the cellular (cells) and corresponding soluble fractions (media) were analyzed by immunoblotting. -CW antibodies raised against the CW peptide K 33 RRHPKK 39 detected N-terminal processing of released proteins, -HA antibodies detected the C-terminal tag, and polyclonal -Shh antibodies detected full-length and truncated proteins on the same (stripped) blot. To better demonstrate Shh processing during release, we inverted and colored the gray scale blots (green: -Shh signal, red: -CW signal, blue: -HA signal). Signals of increased electrophoretic mobility therefore denote C-processed/N-unprocessed soluble proteins, and most mobile green signals confirm the removal of N-and C-terminal peptides. Scube2 increased the release of all lipidated Shh forms (compare lipidated proteins + Scube released into the media with proteins expressed in the absence of Scube2) and converted cellular Shh and Shh HA into truncated soluble morphogens. This is indicated by an electrophoretic size shift and lack of -CW and all -HA antibody reactivity. Cell-surface-associated Shh C25A;HA was completely C-terminally processed (yellow band, compare with Shh HA ) and also underwent partial N-terminal processing (green band) [20] .
Supplementary Figure S3 . Proteolytic Shh truncation at the surface of cancer cells. (A) In Bosc23 cells in the presence of the unspecific sheddase-activator methyl--cyclodextrin, a substantial fraction of soluble Shh C25S is released in N-terminally unprocessed form. This is indicated by its unchanged electrophoretic mobility, but proteolytic CW processing truncates the remaining fraction and increases its electrophoretic mobility (bottom band, asterisk). Shh C25S N-truncation was also observed in HeLa (adenocarcinoma) (n = 12 assays), Panc1 (pancreatic carcinoma) (n = 6), and MiaPaCa (pancreatic
